Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
John Abele, Founder, Boston Scientific Corporation, discusses the dilemma of regulating medicine when it comes to the risk of not doing something versus the risk of doing something.…
Chris Longhurst, MD, Associate Professor, Stanford Medical School, gives insight on the future of a fully digital healthcare system. By 2020, a nationwide learning healthcare system will allow…
Clark Chen, MD, PhD explains that the most common form of brain cancer, glioblastoma, is also one of the most deadly cancers. Despite efforts to find treatments and…
Researchers at a university in eastern Zhejiang Province have used a 3D printer to create living kidneys, which are expected to be used for transplants in the future.
NEW YORK (Reuters Health) – A multinational study has shown that progression-free survival in elderly patients with untreated metastatic colorectal cancer (CRC) is improved significantly when bevacizumab is…
NEW YORK (Reuters Health) – Elderly patients with unresected stage III non-small-cell lung cancer (NSCLC) who are not candidates for chemoradiotherapy benefit from radiation therapy (RT) alone, according…
More than 200,000 Americans suffer ACL injuries each year, most of them young and physically active. Many struggle with the decision to undergo ACL repair, or to stick…
Consistent exercise and physical movement have been proven to be beneficial for bones and joints, mental health, and overall well-being. The Scripps Research Institute is now using the wearable…
The most common complication for a patient while in the hospital is an infection, especially for very sick patients who require a stay in an intensive care unit.…
NEW YORK (Reuters Health) – After resection of pancreatic adenocarcinoma, chemotherapy with fluorouracil or gemcitabine reduces mortality by about a third, Taiwanese researchers have shown. On the other…
